| 查看: 2992 | 回复: 9 | ||
[求助]
谁帮忙查个盐酸美金刚的标准，谢谢了。
|
|
谁帮忙查个盐酸美金刚的标准，谢谢了。 一定要USP36的， |
回复此楼» 猜你喜欢
广西医科大学基础医学院自身免疫病课题组招收基础医学、药学和生物学等专业的研究生
已经有7人回复
-
2025年药学专业求调剂
已经有1人回复
-
药理学论文润色/翻译怎么收费?
已经有198人回复
-
[学习资料分享] FAERS数据库的不良反应挖掘(频数法/贝叶斯法)
已经有1人回复
-
招收医学、基础医学类调剂研究生
已经有0人回复
-
是否属于脾肾阳虚证
已经有0人回复
-
292药学调剂
已经有1人回复
-
广西医科大学基础医学院自身免疫病课题组招收基础医学相关专业的调剂研究生
已经有2人回复
» 本主题相关价值贴推荐，对您同样有帮助:
e_liang369
金虫 (正式写手)
- 应助: 340 (大学生)
- 金币: 2491.9
- 红花: 12
- 帖子: 819
- 在线: 737.3小时
- 虫号: 2456033
- 注册: 2013-05-09
- 性别: GG
- 专业: 药物分析
2楼2013-10-18 12:28:32
3楼2013-10-19 20:33:53
qiuqinglei5020 
金虫 (小有名气)
硫酸大师
- 应助: 2 (幼儿园)
- 金币: 131
- 散金: 27
- 红花: 6
- 帖子: 138
- 在线: 71.3小时
- 虫号: 1083266
- 注册: 2010-08-27
- 性别: GG
- 专业: 药物分析
4楼2013-10-20 12:24:43
06药学
木虫 (著名写手)
- DRDEPI: 1
- 应助: 24 (小学生)
- 金币: 6679.8
- 散金: 16
- 红花: 3
- 帖子: 1041
- 在线: 543.6小时
- 虫号: 525221
- 注册: 2008-03-14
- 性别: GG
- 专业: 药物分析
【答案】应助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★
感谢参与，应助指数 +1
hfsr(zhychen2008代发): 金币+10, 多谢回帖交流 2013-10-20 23:08:46
感谢参与，应助指数 +1
hfsr(zhychen2008代发): 金币+10, 多谢回帖交流 2013-10-20 23:08:46
|
Memantine Hydrochloride Tablets DEFINITION Memantine Hydrochloride Tablets contain an amount of memantine hydrochloride equivalent to NLT 90.0% and NMT 110.0% of the labeled amount of memantine hydrochloride (C12H21N ·HCl). IDENTIFICATION • A. Infrared Absorption 197K Analytical range: 4000 to 400 cm –1 Standard: 6.7 mg/mL of USP Memantine Hydrochloride RS in dichloromethane. Shake for 10 min, and pass through a suitable filter. Evaporate the solvent at room temperature. Collect the residue powder, and dry at 60 for 15 min. Prepare an approximate 1% (w/w) dispersion of the sample in potassium bromide. Sample: 6.7 mg/mL of Memantine Hydrochloride in dichloromethane from NLT 20 crushed Tablets. Shake for 10 min, and centrifuge for 10 min. Pass the supernatant through a suitable filter. Evaporate the solvent at room temperature. Collect the residue powder, and dry at 60 for 15 min. Prepare an approximate 1% (w/w) dispersion of the sample in potassium bromide. Acceptance criteria: Fingerprint region of the Standard and Sample spectrum exhibit maxima at the same wave numbers. • B. The retention time of the memantine peak in the Sample solution corresponds to that of the memantine peak in the Standard solution, as obtained in the Assay. ASSAY • Procedure Solution A: 200 mg/mL of sodium hydroxide in water Internal standard solution: 25 µg/mL of USP Amantadine Hydrochloride RS in water Standard stock solution: 25 µg/mL of USP Memantine Hydrochloride RS prepared as follows. Weigh a suitable quantity of the Standard into a volumetric flask. Add methanol to fill 40% of the final flask volume, and sonicate. Dilute with water to volume. Standard solution: Pipet 4.0 mL each of Internal standard solution and Standard stock solution into a test tube. Add 2 mL of Solution A, and mix on a vortex mixer for 1 min. Add 4 mL of toluene, and mix on a vortex mixer for 3 min. Allow the two layers to separate. Inject the toluene layer. Sample stock solution: Nominally 20 µg/mL of memantine hydrochloride prepared as follows. Transfer a suitable number of Tablets to a volumetric flask to obtain a 0.1 mg/mL memantine hydrochloride solution. Add methanol to fill 40% of the final flask volume, and sonicate for 30 min with intermittent shaking. Add water to fill 40% of the final flask volume, and sonicate for 30 min with intermittent shaking. Dilute with water to volume, and centrifuge a portion for 10 min. Pipet a suitable volume of the clear centrifugate into a volumetric flask, and dilute with water to volume. Sample solution: Pipet 5.0 mL of the Sample stock solution, 4.0 mL of Internal standard solution, and 2 mL of Solution A into a test tube, and mix on a vortex mixer for 1 min. Add 4 mL of toluene, and mix on a vortex mixer for 5 min. Allow the two layers to separate. Inject the toluene layer. Blank: To 5.0 mL of 80 µL/mL of methanol in water add 2 mL Solution A, and mix on a vortex mixer for 1 min. Add 4.0 mL of tolune, and cyclomix on vortex for 5 min. Allow the two layers to separate. Inject the toluene layer. Chromatographic system (See Chromatography 621 , System Suitability.) Mode: GC Detector: Flame ionization Column: 30-m × 0.32-mm; 0.25-µm packing G27 Temperatures Injection port: 210 Detector: 300 Oven: See Table 1. Table 1 Initial Temperature () Temperature Ramp (/min) Final Temperature () Hold Time at Final Temperature (min) 50 0 50 2 50 20 140 0 140 30 200 5 Carrier gas: Helium Flow rate: 34.8 psi Injection volume: 4 µL Injection type: Split ratio, 1:10 System suitability Sample: Standard solution [ NOTE— The relative retention times for amantadine and memantine are 0.97 and 1.0, respectively. ] Suitability requirements Resolution: NLT 2.0 between amantadine and memantine Tailing factor: NMT 2.5 for amantadine and NMT 2.0 for memantine Relative standard deviation: NMT 2.0% for the ratio of the peak areas of amantadine and memantine Analysis Samples: Standard solution, Sample solution, and Blank Calculate the percentage of the labeled amount of memantine hydrochloride (C12H21N ·HCl) in the portion of Tablets taken: Result = ( R U / R S ) × ( C S / C U ) × 100 R U = peak area ratio of memantine to amantadine from the Sample solution R S = peak area ratio of memantine to amantadine from the Standard solution C S = concentration of USP Memantine Hydrochloride RS in the Standard solution (µg/mL) C U = nominal concentration of memantine hydrochloride in the Sample solution (µg/mL) Acceptance criteria: 90.0%–110.0% PERFORMANCE TESTS • Dissolution 711 Medium: 0.1 N hydrochloric acid with sodium chloride (2g/L of sodium chloride in water), adjusted with hydrochloric acid to a pH of 1.2; 900 mL Apparatus 1: 100 rpm Time: 30 min Standard stock solution: (L/900) mg/mL of USP Memantine Hydrochloride RS in Medium, where L is the label claim in mg/Tablet Internal standard solution: 28 µg/mL of USP Amantadine Hydrochloride RS in Medium Standard solution For Tablets labeled to contain 5 mg: Transfer 5 mL of the Standard stock solution to a test tube, add 1 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer. For Tablets labeled to contain 10mg: Transfer 5 mL of the Standard stock solution to a test tube, add 2 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer. Sample solution: Pass a portion of the solution under test through a suitable filter. For Tablets labeled to contain 5 mg: Transfer 5 mL of the filtrate to a test tube, add 1 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer. For Tablets labeled to contain 10 mg: Transfer 5 mL of the filtrate to a test tube, add 2 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer. Chromatographic system (See Chromatography 621 , System Suitability.) Mode: GC, splitless Detector: Flame ionization Column: 30-m × 0.32-mm; 0.25-µm packing G27 Flow rate: 34.8 psi Temperatures Injection port: 210 Detector: 300 Oven: See Table 2. Table 2 Initial Temperature () Temperature Ramp (/min) Final Temperature () Hold Time at Final Temperature (min) 50 0 50 2 50 20 140 0 140 30 200 5 Carrier gas: Helium Injection volume: 4 µL System suitability Sample: Standard solution Suitability requirements Resolution: NLT 2.0 between amantadine and memantine Tailing factor: NMT 2.0 each for amantadine and memantine Relative standard deviation: NMT 2.0% for both the amantadine and memantine peaks Analysis Samples: Standard solution and Sample solution Calculate the percentage of the labeled amount of memantine hydrochloride (C12H21N ·HCl) dissolved: Result = ( R u / R s ) × ( C s /L) × V × 100 R U = peak area ratio of memantine to amantadine from the Sample solution R S = peak area ratio of memantine to amantadine from the Standard solution C S = concentration of USP Memantine Hydrochloride RS from the Standard solution (µg/mL) V = volume of Medium, 900 mL L = label claim (mg/Tablet) Tolerances: NLT 80% (Q) of the labeled amount of memantine hydrochloride (C12H21N ·HCl) is dissolved. • Uniformity of Dosage Units 905 : Meet the requirements IMPURITIES • Limit of Memantine–Lactose Adduct [ NOTE— Perform this test if lactose is present in the formulation. ] Solution A: 40 mg/mL of sodium hydroxide in water Buffer: Dissolve 3.3 g of monobasic potassium phosphate and 2.3 g of sodium 1-octane sulfonate in 1 L of water. Adjust with Solution A to a pH of 6.1. Mobile phase: Acetonitrile, methanol, and Buffer (26:4:70) Standard solution: 0.2 mg/mL of USP Memantine Hydrochloride RS in Mobile phase Sample solution: Nominally 10 mg/mL of memantine hydrochloride from NLT 25 crushed Tablets, prepared as follows. Transfer an amount of powder equivalent to 100 mg of memantine hydrochloride to a 20-mL volumetric flask. Add 10 mL of Mobile phase, and sonicate for 30 min. Centrifuge, and pass a portion of the centrifugate through a suitable filter of 0.45-µm pore size. Chromatographic system (See Chromatography 621 , System Suitability.) Mode: LC Detector: Refractive index Column: 4.6-mm × 15-cm; 5-µm packing L1 Temperatures Column: 40 Detector: 35 Flow rate: 1.3 mL/min Injection volume: 50 µL Run time: 1.3 times the retention time of the memantine peak System suitability Sample: Standard solution Suitability requirements Tailing factor: NMT 3.5 Relative standard deviation: NMT 10.0% Analysis Samples: Standard solution and Sample solution Calculate the percentage of the memantine–lactose adduct in the portion of Tablets taken: Result = ( r U / r S ) × ( C S / C U ) × (1/F) × 100 r U = peak response of the memantine–lactose adduct from the Sample solution r S = peak response of memantine from the Standard solution C S = concentration of USP Memantine Hydrochloride RS in the Standard solution (mg/mL) C U = nominal concentration of memantine hydrochloride in the Sample solution (mg/mL) F = relative response factor of the memantine–lactose adduct (see Table 3) Acceptance criteria: See Table 3. Disregard all peaks other than the memantine–lactose adduct peak. Table 3 Name Relative Retention Time Relative Response Factor Acceptance Criteria, NMT (%) Memantine–lactose adduct 0.41 0.53 0.5 Memantine 1.0 1.0 — • Organic Impurities Solution A: 1 N sodium hydroxide Standard stock solution A: 0.5 mg/mL each of USP Memantine Related Compound A RS, USP Memantine Related Compound B RS, USP Memantine Related Compound C RS, USP Memantine Related Compound D RS, and USP Memantine Related Compound E RS in n-hexane Standard stock solution B: 12.5 mg/mL of USP Memantine Hydrochloride RS prepared as follows. Weigh a suitable quantity of the Standard into a volumetric flask. Add Solution A to fill 15% of the final flask volume and n-hexane to fill 10% of the final flask volume. Mix for 10 min. System suitability solution: Pipet 4.0 mL of the n-hexane layer from Standard stock solution B into a 10-mL volumetric flask. Add 0.5 mL of Standard stock solution A, and dilute with n-hexane to volume. Standard stock solution: 1.3 mg/mL of USP Memantine Hydrochloride RS in n-hexane prepared as follows. Weigh a suitable quantity of the Standard into a volumetric flask. Add Solution A to fill 30% of the final flask volume, and mix for 5 min. Add n-hexane to fill 40% of the final flask volume, and shake for 10 min. Transfer the contents of the flask into a separator. Allow the layers to separate, and filter a portion of the top n-hexane layer through anhydrous sodium sulfate. Use the clear solution. Standard solution: Pipet 2.0 mL of the clear solution from the Standard stock solution into a 100-mL volumetric flask, and dilute with n-hexane to volume. Sample solution: Nominally 5 mg/mL of memantine hydrochloride in n-hexane from NLT 20 crushed Tablets, prepared as follows. Transfer a weighed amount of powder equivalent to 100 mg of memantine hydrochloride to a suitable volumetric flask. Add Solution A to fill 15% of the final flask volume. Shake to disperse the material, and shake for 5 min. Sonicate for 5 min with intermittent shaking. Add n-hexane to fill 20% of the final flask volume, and shake for 10 min. Transfer the contents into a separator. Allow the layers to separate, and filter a portion of the top hexane layer through anhydrous sodium sulfate. Use the clear solution. Chromatographic system (See Chromatography 621 , System Suitability.) Mode: GC Detector: Flame ionization Column: 50-m × 0.32-mm; 0.52-µm packing G27 Temperatures Injection port: 220 Detector: 300 Oven: See Table 4. Table 4 Initial Temperature () Temperature Ramp (/min) Final Temperature () Hold Time at Final Temperature (min) 50 0 50 2 50 5 145 0 145 10 250 20 Carrier gas: Helium Flow rate: 4.0 ± 0.2 mL/min Injection volume: 3 µL Injection type: Split ratio, 1:20 System suitability Samples: System suitability solution and Standard solution [ NOTE— See Table 5 for the relative retention times. ] Suitability requirements Resolution: NLT 2.0 between memantine and memantine related compound B, NLT 2.0 between memantine related compound B and memantine related compound C, System suitability solution Tailing factor: NMT 2.0, Standard solution Relative standard deviation: NMT 10.0%, Standard solution Analysis Samples: Standard solution and Sample solution Calculate the percentage of USP Memantine Related Compound E RS or any individual degradation product in the portion of Tablets taken: Result = ( r U / r S ) × ( C S / C U ) × 100 r U = peak response of USP Memantine Related Compound E RS or any individual degradation product from the Sample solution r S = peak response of memantine hydrochloride from the Standard solution C S = concentration of USP Memantine Hydrochloride RS in the Standard solution (mg/mL) C U = nominal concentration of memantine hydrochloride in the Sample solution (mg/mL) Acceptance criteria: See Table 5. Table 5 Name Relative Retention Time Acceptance Criteria, NMT (%) Memantine related compound Aa 0.77 — Memantine 1.0 — Memantine related compound Ba 1.03 — Memantine related compound Ca 1.1 — Memantine related compound Da 1.2 — Memantine related compound E 1.4 0.15 Any individual unspecified degradation product — 0.20 Total impuritiesb — 0.5 a Process impurities controlled in the drug substance and are included for identification only. Not reported for the drug product and not included in the total impurities b Excludes memantine–lactose adduct monitored in the test for Limit of Memantine–Lactose Adduct. ADDITIONAL REQUIREMENTS • Packaging and Storage: Preserve in tight containers. Store at controlled room temperature. • USP Reference Standards 11 USP Amantadine Hydrochloride RS USP Memantine Hydrochloride RS USP Memantine Related Compound A RS 1,3-Dimethyladamantane. C12H20 164.29 USP Memantine Related Compound B RS 3,5-Dimethyladamantane-1-ol. C12H20O 180.29 USP Memantine Related Compound C RS 1-Chloro-3,5-dimethyladamantane. C12H19Cl 198.73 USP Memantine Related Compound D RS 1-Bromo-3,5-dimethyladamantane. C12H19Br 243.18 USP Memantine Related Compound E RS N-3,5-Dimethyladamantan-1-yl formamide. C13H21NO 207.31 |
» 本帖已获得的红花（最新10朵）
zhangpeino5楼2013-10-20 23:02:07
6楼2013-10-28 21:25:07
7楼2014-01-06 17:07:49
8楼2014-04-10 17:17:59
06药学
木虫 (著名写手)
- DRDEPI: 1
- 应助: 24 (小学生)
- 金币: 6679.8
- 散金: 16
- 红花: 3
- 帖子: 1041
- 在线: 543.6小时
- 虫号: 525221
- 注册: 2008-03-14
- 性别: GG
- 专业: 药物分析
» 本帖已获得的红花（最新10朵）
9楼2014-04-10 20:50:01
10楼2014-04-11 12:27:52
